Skip to content

Complementary medicines in psychiatry: review of effectiveness and safety.

Ursula Werneke, Trevor Turner, Stefan Priebe

The British Journal of Psychiatry February 1, 2006 DOI: 10.1192/bjp.188.2.109 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Keywords Options Mental health Cognition Antidepressant properties Sedative effects Antidepressant treatments Herbal supplements: ginkgo St. john's wort Hydergine Passion flower Valerian S-adenosylmethionine Selenium Folate
Citations 98
Key findings Ginkgo, hydergine, passion flower, valerian, St John's wort, s-adenosylmethionine, selenium, and folate show potential psychotropic benefits, but evidence for other substances is less conclusive.

Abstract

The use of complementary medicines in those with mental health problems is well documented. However, their effectiveness is often not established and they may be less harmless than commonly assumed. To review the complementary medicines routinely encountered in psychiatric practice, their effectiveness, potential adverse effects and interactions. Electronic and manual literature search on the effectiveness and safety of psychotropic complementary medicines. Potentially useful substances include ginkgo and hydergine as cognitive enhancers, passion flower and valerian as sedatives, St John's wort and s-adenosylmethionine as antidepressants, and selenium and folate to complement antidepressants. The evidence is less conclusive for the use of omega-3 fatty acids as augmentation treatment in schizophrenia, melatonin for tardive dyskinesia and 18-methoxycoronaridine, an ibogaine derivative, for the treatment of cocaine and heroin addiction. Systematic clinical trials are needed to test promising substances. Meanwhile, those wishing to take psychotropic complementary medicines require appropriate advice.

Citations in the library

Explore topics